Shows
The Good News About CancerEarly Detection, Part 3: C the SignsA lot of cancers don’t get diagnosed until the disease is somewhat advanced. Dr. Bea Bakshi founded her company, C the Signs, to change that. They use artificial intelligence to comb through medical records and identify when a patient should be screened for cancer – and it catches disease far earlier than a human doctor could. She tells Chuck about their success integrating into the National Health System in the UK, and their plans to launch in the United States.
2025-11-1822 minThe Good News About CancerEarly Detection, Part 2: Screening for Over 50 Cancers with CancerguardA new blood test called Cancerguard is pushing the boundaries of cancer early detection. The test is widely available, and has the ability to screen for more than 50 cancer types. In this episode, Chuck talks with Dr. Tom Beer of Exact Sciences, the company behind the Cancerguard test.
2025-11-1120 minThe Good News About CancerEarly Detection, Part 1: Finding Cancer in the Blood, Years Before SymptomsThe earlier a cancer is detected, the more possibilities there are for effective treatment. In this episode, Chuck and Alicia talk with Dr. Nickolas Papadopoulos about his research into how indications of cancer can show up in the blood, long before symptoms arise.
2025-11-0420 minThe Good News About CancerWhen Exercise Is The PrescriptionWe all know that exercise is good for us, but historically there hasn’t been much data on how much exercise – or what kind of exercise – might have benefits for cancer patients. In this episode, Chuck and Alicia talk with Kerry Courneya of the University of Alberta about his study that looked into the question of exercise for patients with colorectal cancer. The results, which were published in the New England Journal of Medicine, show that exercise could be even better than we think.
2025-10-2822 minThe Good News About CancerWhen Immunotherapy Can Replace SurgeryColorectal cancer rates are on the rise, particularly among young people. And the standard of care treatments can have lifelong impacts on a patient's quality of life – but new immunotherapies could change that. Dr. Andrea Cercek joins Chuck and Alicia to talk about the immunotherapy drug Dostarlimab, which is ushering in a new era of cancer treatment.
2025-10-2125 min
PeerVoice Internal Medicine VideoAlicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With PatientsAlicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With Patients
2025-10-0230 min
PeerVoice Internal Medicine AudioAlicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With PatientsAlicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With Patients
2025-10-0230 min
PeerVoice Oncology & Haematology VideoAlicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With PatientsAlicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With Patients
2025-10-0230 min
PeerVoice Oncology & Haematology AudioAlicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With PatientsAlicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With Patients
2025-10-0230 min
OncLive® On AirFDA Approval Insights: Darolutamide for Metastatic Castration-Sensitive Prostate Cancer: With Alicia Morgans, MD, MPH; and Neal Shore, MD, FACSIn today’s episode, supported by Bayer, we had the pleasure of speaking with Alicia Morgans, MD, MPH, and Neal Shore, MD, FACS, about the FDA approval of darolutamide (Nubeqa) plus androgen deprivation therapy for patients with metastatic castration-sensitive prostate cancer (mCSPC). Morgans is the medical director of the survivorship program at Dana-Farber Cancer Institute; as well as an associate professor of medicine at Harvard Medical School, both in Boston, Massachusetts. Shore is the medical director of the Carolina Urologic Research Center.In our exclusive interview, Drs Morgans and Shore discussed the significance of this approval; key efficacy, sa...
2025-07-0316 min
Adis Journal PodcastsA Podcast on Integrating Genetic Testing for Homologous Recombination Repair Gene Alterations in Patients with Prostate Cancer in the USA: a Multidisciplinary Approach to Overcoming the ObstaclesIn this podcast, Dr. Brittany M. Szymaniak from the Feinberg School of Medicine at Northwestern University, Chicago, IL, USA, Dr. Alicia K. Morgans from the Dana-Farber Cancer Institute, Boston, MA, USA, and Dr. Neal D. Shore from the Carolina...
In this podcast, Dr. Brittany M. Szymaniak from the Feinberg School of Medicine at Northwestern University, Chicago, IL, USA, Dr. Alicia K. Morgans from the Dana-Farber Cancer Institute, Boston, MA, USA, and Dr. Neal D. Shore from the Carolina Urologic Research Center, Myrtle Beach, SC, USA, aim to identify obstacles to testing for homologous recombination repair (HRR) gene alterations in...
2025-06-2921 min
OncLive® On AirThe Expanding Role of AR Inhibition in mHSPC Management: With Alicia Morgans, MD, MPHIn our exclusive interview, Dr Morgans detailed the evolving role of AR inhibitors in the mHSPC setting, including the recent expanded approval for darolutamide (Nubeqa) for this population. She discussed treatment considerations for determining whether to give docetaxel along with darolutamide; other factors to remember with AR inhibition; and the need to continue driving consensus across practices in the management of prostate cancer.
2025-06-1611 minThe Good News About CancerThe Story Behind Imatinib, the First Targeted Cancer TreatmentBefore the early 2000s, there were no effective treatments for chronic myelogenous leukemia, a blood cancer. Then came Imatinib. This drug dramatically improved survival and quality of life for patients with this disease. It also ushered in a new era of cancer treatment, with drugs that directly target tumor cells. In this episode, Chuck and Alicia talk with Dr. Brian Druker, a renowned physician scientist who was the main force behind the development of Imatinib.
2025-05-0626 minThe Good News About CancerFrom Breast Cancer Patients to Healthy MothersAs more people live longer and healthier lives following a cancer diagnosis, it brings up all kinds of questions about what is possible and safe. In this episode, Chuck and Alicia talk with Dr. Ann Partridge of Dana-Farber Cancer Institute about her work looking into how breast cancer survivors can have healthy pregnancies.In September, Dana-Farber is hosting the 2025 Cancer Centers Survivorship Research Forum. Find more information and register here: https://www.eventbrite.com/e/cancer-centers-survivorship-research-forum-2025-registration-1270679660069
2025-04-2921 minThe Good News About Cancer21 Million Years of Life Reclaimed from Blood CancersAn estimated 1.6 million people in the U.S. are living with or in remission from blood cancer. Many of these people are children. Today, thanks to the work of clinicians and researchers like Dr. Andy Kolb of the Leukemia and Lymphoma Society, those patients are living longer and undergoing less toxic treatments. In this episode, Dr. Kolb joins Chuck and Alicia to explain how his organization is improving the lives of patients with leukemia, lymphoma, myeloma, and other blood cancers.
2025-04-2222 minThe Good News About CancerHow Melanoma Met its Match: Cancer ImmunotherapyDid you know that the immune system, which keeps us from getting sick, can also be harnessed to fight cancer? In this episode, Dr. Jedd Wolchok of Weill Cornell Medicine explains the major breakthroughs that led to the development of immunotherapy. This revolutionized treatment of metastatic melanoma, and has since been a game-changer in treating many other kinds of cancers.
2025-04-1522 min
The UromigosEpisode 405: The Good News About Cancer podcastDrs. Alicia Morgans and Chuck Ryan join the show to talk about their new podcast.
2025-04-1117 minThe Good News About CancerPreventing Cancer by Understanding Inherited RisksWe all receive genes from our parents, but what happens when our family carries genetic variants that are known to cause cancer? Chuck talks with Dr. Pamela Munster about the specialty clinic she runs at the University of California, San Francisco, for those who have cancers that arise from genetic variants. She also shares her unique experience of being an oncologist who has had breast cancer, and has a BRCA variant herself.
2025-03-1822 minThe Good News About CancerCancer Early Detection: Beyond Mammograms and ColonoscopyWhat if we could detect cancer before it even formed a tumor? That’s what Dr. Margaret Tempero is working on at the Cancer Early Detection and Interception Initiative at the University of California, San Francisco. Chuck talks with Dr. Tempero about advances in early detection through circulating tumor DNA and other approaches. They discuss how new early detection strategies could affect primary care, oncology, and most of importantly, those at risk for cancers.
2025-03-1120 min
touchPODCASTMDT perspectives on the importance of patient engagement in PARPi use - Video 3touchMDT for touchONCOLOGY
Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and practicalities of engaging patients in their care and hear insights from the perspective of a patient advocate in relation to the use of PARP inhibitors.
The multidisciplinary team and patient advocate:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Patient Advocate – Mr Tony Collier
Tackle Prostate Cancer...
2025-03-0613 mintouchPODCASTMDT perspectives on understanding precision medicine to guide PARPi use in mCRPC - Video 2touchMDT for touchONCOLOGY
Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Prof. Albrecht Stenzinger shares his perspectives as a pathologist with Dr Alicia Morgan and Dr Grace Cullen.
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Pathologist – Prof. Albrecht Stenzinger
University of Heidelberg, Heidelberg, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activi...
2025-03-0613 mintouchPODCASTMDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC - Video 1touchMDT for touchONCOLOGY
MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC
Experts Dr Alicia Morgans and Dr Grace Cullen share insights into using evidence to guide practice and shared decision-making with patients with metastatic castration-resistant prostate cancer (mCRPC).
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
This touchPODCAST is for HCPs outside of the UK only.
This activ...
2025-03-0613 minThe Good News About CancerThe Crucial Role of the National Cancer InstituteThe National Cancer Institute at the National Institutes of Health is a lot more than a group of buildings in Bethesda, Maryland. It’s an institution that provides vital support for cancer research, and connects a national network of cancer centers that treat patients around the country. In this episode, Chuck and Alicia talk with outgoing NCI director, Dr. Kim Rathmell, about the role of the organization and some recent points of progress.
2025-03-0422 minThe Good News About CancerWinning Against HPVOver the past several years, more and more Americans have been vaccinated against HPV, a virus known to cause cervical cancer, head and neck cancer, anal cancer and vaginal cancer, among others. As a result of the HPV vaccine, the cancers caused by this virus have declined significantly, and many lives have been saved. In this episode, Chuck talks with Dr. Ashish Deshmukh about this major public health win.
2025-02-2520 minThe Good News About CancerThe Key that Unlocked Lung CancerChuck and Alicia sit down with Dr. William Pao to hear the story of how he contributed to the discovery of a gene mutation in lung cancer – a discovery that opened up new avenues for treatment, and changed thousands of lives. Find Dr. Pao’s book, Breakthrough, at all major booksellers.
2025-02-1822 minThe Good News About Cancer4.75 Million Lives Saved, and CountingTo kick off The Good News About Cancer, Chuck and Alicia sit down with Karen Knudsen, the outgoing CEO of the American Cancer Society, to talk about some of the biggest wins in cancer prevention and treatment.
2025-02-1123 minThe Good News About CancerWelcome to The Good News About CancerDid you know there was good news about cancer?In each episode of The Good News About Cancer, Dr. Charles Ryan and Dr. Alicia Morgans unpack exciting new developments in cancer prevention, diagnosis, and treatment. Subscribe today wherever you get podcasts.
2025-01-1000 min
Battalion-13 The PodcastBattalion-13 The Podcast Episode 9: The Funeral Last time on Battalion-13 The Podcast; The group learned of Madelyn's suicide and began making plans to go home. A Battalion-13 Entertainment, Inc. Production Join our Fan Group!B-13 Fan Group on FB Sign up for our mailing list:https://mailchi.mp/679733bf187e/battalion13hq Live Journal: https://battalion-13.livejournal.com/309.html This is a work of fiction. Names, characters, businesses, places, events, locales, and incidents are either the products of the author’s imagination or used in a fictitious manner. Any resemblance to actual persons, living or dead, or actual events is purely coincidental. Written and Edited...
2024-11-151h 16Battalion-13 The PodcastBattalion-13 The Podcast Episode 8: Denial A Battalion-13 Entertainment, Inc. Production Join our Fan Group!B-13 Fan Group on FB Sign up for our mailing list:https://mailchi.mp/679733bf187e/battalion13hq Live Journal: https://battalion-13.livejournal.com/309.html This is a work of fiction. Names, characters, businesses, places, events, locales, and incidents are either the products of the author’s imagination or used in a fictitious manner. Any resemblance to actual persons, living or dead, or actual events is purely coincidental. Written and Edited by: Gandalf Clarke, Ellen Clarke, Jaime Gentry, Jason Aumen, Dawnsk Morgans and Rob the Diceman Smith Executive Producer...
2024-11-151h 08
GU Cast | Urology PodcastThree big challenges in metastatic prostate cancer | Dr Alicia MorgansToday we have Dr Alicia Morgans, GU Medical Oncologist and Director of Survivorship at Dana Farber Cancer Institute, in the GU Cast studio for a chat. We wanted to ask Alicia to look forward and identify three big challenges we will face in metastatic prostate cancer over the next 5-10 years. What did we come up with??!! Tune in to find out!!Even better on our YouTube channel
2024-05-1938 min
Medical News PodcastSpecialist Spotlight: Urothelial Carcinoma Update From the ASCO GU Symposium 2024Drs. Alicia Morgans and Jonathan Rosenberg share their insights into some interesting abstracts from the 2024 ASCO GU symposium: one covering a model to help predict response to neoadjuvant chemotherapy in patients with muscle invasive UC, and another regarding results from the PemCab study of pembrolizumab and cabozantinib in first‑line advanced UC.
2024-05-1810 minMedical News PodcastASCO Genitourinary Symposium 2024: Late‑Breaking Presentations on EV‑302 and AMBASSADORDrs. Jonathan Rosenberg and Alicia Morgans share their insights into some late-breaker abstracts presented at the 2024 ASCO GU symposium in San Francisco. The first is a subgroup analysis from EV‑302 with enfortumab vedotin and pembrolizumab, and the other is AMBASSADOR, which looks at adjuvant pembrolizumab in locally advanced and muscle invasive urothelial cancer.
2024-05-1710 minMedical News PodcastSpecialist Spotlight: Advanced Urothelial Carcinoma: Considerations in Therapeutic SequencingDrs. Alicia Morgans and Jonathan Rosenberg share their insights into therapeutic sequencing in patients with advanced urothelial cancer, reviewing patient selection and timing, options following progression on immunotherapy, and future therapeutic agents such as HER2‑targeted ADCs.
2024-05-1610 min
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastAlicia K. Morgans, MD, MPH, Neal D. Shore, MD, FACS - Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration ApproachesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CJD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until April 24, 2025.Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches...
2024-05-0959 minMedical News PodcastSpecialist Spotlight: Alicia Morgans, MD, MPH on the Care of Cancer SurvivorsAlicia Morgans, MD, MPH, a genitourinary oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute, discusses the intricate coordination required for the care of cancer survivors, including strategies for structuring programs that support patients following their cancer treatment. Additionally, she addresses the role of a survivorship clinic in facilitating the transition of care from oncology to primary care. This transition takes into consideration the patients' physical, mental, and sexual health.
2024-04-0321 minMedical News PodcastSpecialist Spotlight: Jonathan E. Rosenberg, MD and Alicia K. Morgans, MD, MPH on Late‑Breaking Presentations on EV‑302 and AMBASSADOR at ASCO Genitourinary Symposium 2024Drs. Rosenberg and Morgans share their insights into some late-breaker abstracts presented at the 2024 ASCO GU symposium in San Francisco. The first is a subgroup analysis from EV‑302 with enfortumab vedotin and pembrolizumab, and the other is AMBASSADOR, which looks at adjuvant pembrolizumab in locally advanced and muscle invasive urothelial cancer.
2024-03-1610 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...
2024-03-011h 25
PeerView Clinical Pharmacology CME/CNE/CPE VideoRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...
2024-03-011h 24PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...
2024-03-011h 25
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...
2024-03-011h 24
PeerView Oncology & Hematology CME/CNE/CPE Video PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...
2024-03-011h 24
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...
2024-03-011h 25PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...
2023-12-221h 04PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...
2023-12-221h 04PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...
2023-12-221h 04
PeerView Internal Medicine CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...
2023-12-221h 04PeerView Oncology & Hematology CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...
2023-12-221h 04PeerView Clinical Pharmacology CME/CNE/CPE VideoNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...
2023-12-221h 04
PeerView Internal Medicine CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...
2023-12-221h 04PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...
2023-12-221h 04
The Dr. Geo Prostate PodcastIntermittent Androgen Deprivation Therapy (ADT) in Prostate Cancer with Alicia Morgans, MDIn this insightful episode of our podcast, Dr. Geo sits down with the distinguished Dr. Alicia Morgan, a genital urinary medical oncologist at Dana-Farber Cancer Institute and the medical director of their survivorship program. This conversation is particularly close to the heart of many of our listeners who have shared their concerns about prostate cancer treatment, especially regarding androgen deprivation therapy (ADT).Dr. Morgan, known for her patient-centered approach, brings her wealth of experience in clinical trials and patient-reported outcomes. She discusses the importance of integrating patient preferences and beliefs into clinical decision-making, a philosophy that aligns...
2023-12-1346 min
COR2ED - Oncology Medical ConversationProstate cancer: Shared decision-making in nmCRPCBrenda Martone, a nurse practitioner at Northwestern Medicine in Chicago Illinois and Dr Alicia Morgans, Genitourinary Medical Oncologist at the Dana-Farber Cancer Institute in the United States discuss ‘Shared decision-making in nmCRPC: Treatment considerations to maintain quality of life’ in this GU CONNECT podcast.
In this podcast, the experts discuss how patients are more likely to be able to adhere to a treatment plan if they understand their choices and the implications of each treatment.
They discuss how nmCRPC patients are relatively asymptomatic and the importance of understanding the patients’ goals of treatment and how these m...
2023-12-0623 minCOR2ED - Oncology Medical ConversationProstate cancer: Highlights from ASCO GU 2022COR2ED Medical Education: Dr Alicia Morgans, Genitourinary Medical Oncologist at the Dana-Farber Cancer Institute in the United States and Dr. Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States discuss ‘Prostate Cancer Highlights from ASCO GU 2022’ in this GU CONNECT podcast.
In this podcast, the experts review data from a number of key plenary sessions from ASCO GU 2022 and discuss potential implications for clinical practice. The ARASENS trial is covered first which looked at triplet therapy in the form of ADT plus docetaxel and darolutamide in pati...
2023-12-0638 minCOR2ED - Oncology Medical ConversationProstate cancer: PARP inhibitors in prostate cancerCOR2ED Medical Education: Dr Jason Alcorn, nurse consultant for Uro-Oncology & Andrology at the Mid Yorkshire Hospitals NHS Trust, United Kingdom and Dr Alicia Morgans, Genitourinary Medical Oncologist and Medical Director of the Survivorship Program at the Dana-Farber Cancer Institute in the United States, discuss 'PARP inhibitors in prostate cancer: Management of adverse events and the importance of communication with patients’ as part of the GU NURSES CONNECT podcast series covering ‘PARP inhibitors in prostate cancer’.
In this podcast, the experts discuss adverse events associated with PARP inhibitors and the management of them, in particular thrombocytopenia, gastrointestinal effect...
2023-12-0626 min
Research To Practice | Oncology VideosChronic Lymphocytic Leukemia | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research InstituteFeaturing perspectives from Dr Tanios Bekaii-Saab, Dr Harold Burstein, Dr Asher Chanan-Khan, Dr Komal Jhaveri, Dr Brad S Kahl, Dr Alicia K Morgans, Dr Philip A Philip, Dr Gregory J Riely, Dr Matthew R Smith and Dr Heather Wakelee, including the following topics: Introduction (0:00) Chronic Lymphocytic Leukemia (CLL): Considerations for Front-Line Treatment — Dr Kahl (1:48) Treatment of Relapsed/Refractory CLL; Novel and Investigational Strategies — Dr Chanan-Khan (35:38) Clinical Questions and Cases (49:58) CME information and select publications
2023-10-2753 min
Research To Practice | Oncology VideosColorectal and Gastroesophageal Cancers | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research InstituteFeaturing perspectives from Dr Tanios Bekaii-Saab, Dr Harold Burstein, Dr Asher Chanan-Khan, Dr Komal Jhaveri, Dr Brad S Kahl, Dr Alicia K Morgans, Dr Philip A Philip, Dr Gregory J Riely, Dr Matthew R Smith and Dr Heather Wakelee, including the following topics: Introduction (0:00) Gastroesophageal Cancers — Dr Philip (1:42) Colorectal Cancer — Dr Bekaii-Saab (32:56) CME information and select publications
2023-10-271h 02
Research To Practice | Oncology VideosNon-Small Cell Lung Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research InstituteFeaturing perspectives from Dr Tanios Bekaii-Saab, Dr Harold Burstein, Dr Asher Chanan-Khan, Dr Komal Jhaveri, Dr Brad S Kahl, Dr Alicia K Morgans, Dr Philip A Philip, Dr Gregory J Riely, Dr Matthew R Smith and Dr Heather Wakelee, including the following topics: Introduction (0:00) Non-Small Cell Lung Cancer Targeted Therapy — Dr Riely (4:09) Non-Small Cell Lung Cancer: Immunotherapeutic and Other Novel Strategies — Dr Wakelee (32:23) CME information and select publications
2023-10-271h 01
Research To Practice | Oncology VideosProstate Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research InstituteFeaturing perspectives from Dr Tanios Bekaii-Saab, Dr Harold Burstein, Dr Asher Chanan-Khan, Dr Komal Jhaveri, Dr Brad S Kahl, Dr Alicia K Morgans, Dr Philip A Philip, Dr Gregory J Riely, Dr Matthew R Smith and Dr Heather Wakelee, including the following topics: Introduction (0:00) Role of Hormonal Therapy in Prostate Cancer Management — Dr Smith (1:50) Clinical Questions and Cases (13:18) Evidence-Based Use of Other Therapeutic Approaches in Metastatic Castration-Resistant Prostate Cancer — Dr Morgans (26:08) Clinical Questions and Cases (38:01) CME information and select publications
2023-10-2758 min
Research To Practice | Oncology VideosER-Positive Breast Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research InstituteFeaturing perspectives from Dr Tanios Bekaii-Saab, Dr Harold Burstein, Dr Asher Chanan-Khan, Dr Komal Jhaveri, Dr Brad S Kahl, Dr Alicia K Morgans, Dr Philip A Philip, Dr Gregory J Riely, Dr Matthew R Smith and Dr Heather Wakelee, including the following topics: Introduction (0:00) ER-Positive Breast Cancer — Dr Burstein (3:57) Clinical Questions and Cases (16:47) Selection and Sequencing of Treatment for Relapsed ER-Positive Metastatic Breast Cancer — Dr Jhaveri (33:32) Clinical Questions and Cases (46:02) CME information and select publications
2023-10-2759 min
WEEI/NESN Jimmy Fund Radio-TelethonAustin Martin, 46, prostate cancer, Needham, with Alicia Morgans, MD, MPH, Medical Director, Survivorship Program, Dana-FarberWhen Austin switched to a new primary care doctor, his wife, Lindsay, told him to ask for everything at his first appointment, including a PSA levels check. Even though nurse practitioners don’t typically check for this at age 45, Austin requested and got it done anyway. That night, the doctor’s office called back and informed him that his PSA was off the charts. They originally thought it was high because he exercised, but after rerunning it, the results were the same. A biopsy confirmed that Austin had a rare type of prostate cancer called small-cell prostate cancer and he b...
2023-08-2906 min
Research To Practice | Oncology VideosProstate Cancer | Second Opinion: Investigators Discuss How They and Their Colleagues Apply Available Clinical Research in the Care of Patients with Prostate CancerFeaturing perspectives from Dr Emmanuel S Antonarakis, Prof Karim Fizazi, Dr Rana R McKay, Dr Alicia K Morgans and Dr A Oliver Sartor, including the following topics: Current Management of Nonmetastatic Prostate Cancer Introduction (0:00) Case: A man in his early 70s diagnosed with localized prostate cancer who underwent a radical prostatectomy in 2010 experiences rising prostate-specific antigen (PSA) from 0.18 to 0.4; PSA doubling time 7 months; PSMA PET-negative for other sites of disease — David S Morris, MD (1:26) Case: A man in his early 70s with M0 hormone-sensitive prostate cancer (HSPC) with PSA persistence after radical prostatectomy received androgen deprivation therapy (ADT) in...
2023-07-122h 00
Prostate Cancer Clinical Masterclass SeriesEpisode 9 - June 2023 - Prostate Cancer Masterclass SeriesThis month we are joined by Dr Osama Mohamad, from University of California, San Francisco, who will help to add clarity around the very current question of ‘Will Artificial Intelligence Ever Substitute for Pathologists?’. We will also hear from Prof Alicia Morgans, from Dana-Farber Cancer Institute, Massachusetts, who will present her thoughts on the topic of 'Strategies for Survivorship’. It is co-chaired by Dr Gerhardt Attard, from University College London, U.K., who leads the group disucssion to close the episode.
2023-06-051h 05PeerVoice Oncology & Haematology AudioAlicia K. Morgans, MD, MPH - What Would You Do Next? Exploring Expert Perspectives on Clinical Cases and Compelling Questions in mHSPC and nmCRPCAlicia K. Morgans, MD, MPH - What Would You Do Next? Exploring Expert Perspectives on Clinical Cases and Compelling Questions in mHSPC and nmCRPC
2023-04-0534 minPeerVoice Oncology & Haematology VideoAlicia K. Morgans, MD, MPH - What Would You Do Next? Exploring Expert Perspectives on Clinical Cases and Compelling Questions in mHSPC and nmCRPCAlicia K. Morgans, MD, MPH - What Would You Do Next? Exploring Expert Perspectives on Clinical Cases and Compelling Questions in mHSPC and nmCRPC
2023-04-0536 minPeerView Internal Medicine CME/CNE/CPE Audio PodcastRana R. McKay, MD, Alicia K. Morgans, MD, MPH - Alicia K. Morgans, MD, MPH - Case by Case: Maximizing Personalized Approaches to Prostate CancerGo online to PeerView.com/YGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The expanding therapeutic landscape for prostate cancer has provided new opportunities for oncology and urology professionals to improve outcomes through individualized patient care. With new and emerging strategies in both the hormone-sensitive and -resistant settings, treatment of patients with prostate cancer requires knowledge of next-generation anti-androgen agents, PARP inhibitors, and use of immunotherapy, radioligands, and other strategies alone or in active combinations, along with guidelines for testing and treatment. In this activity, urologic oncology experts pair in-depth analysis...
2023-01-0757 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastRana R. McKay, MD, Alicia K. Morgans, MD, MPH - Alicia K. Morgans, MD, MPH - Case by Case: Maximizing Personalized Approaches to Prostate CancerGo online to PeerView.com/YGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The expanding therapeutic landscape for prostate cancer has provided new opportunities for oncology and urology professionals to improve outcomes through individualized patient care. With new and emerging strategies in both the hormone-sensitive and -resistant settings, treatment of patients with prostate cancer requires knowledge of next-generation anti-androgen agents, PARP inhibitors, and use of immunotherapy, radioligands, and other strategies alone or in active combinations, along with guidelines for testing and treatment. In this activity, urologic oncology experts pair in-depth analysis...
2023-01-0757 minPeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastRana R. McKay, MD, Alicia K. Morgans, MD, MPH - Alicia K. Morgans, MD, MPH - Case by Case: Maximizing Personalized Approaches to Prostate CancerGo online to PeerView.com/YGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The expanding therapeutic landscape for prostate cancer has provided new opportunities for oncology and urology professionals to improve outcomes through individualized patient care. With new and emerging strategies in both the hormone-sensitive and -resistant settings, treatment of patients with prostate cancer requires knowledge of next-generation anti-androgen agents, PARP inhibitors, and use of immunotherapy, radioligands, and other strategies alone or in active combinations, along with guidelines for testing and treatment. In this activity, urologic oncology experts pair in-depth analysis...
2023-01-0757 minPeerView Clinical Pharmacology CME/CNE/CPE VideoRana R. McKay, MD, Alicia K. Morgans, MD, MPH - Alicia K. Morgans, MD, MPH - Case by Case: Maximizing Personalized Approaches to Prostate CancerGo online to PeerView.com/YGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The expanding therapeutic landscape for prostate cancer has provided new opportunities for oncology and urology professionals to improve outcomes through individualized patient care. With new and emerging strategies in both the hormone-sensitive and -resistant settings, treatment of patients with prostate cancer requires knowledge of next-generation anti-androgen agents, PARP inhibitors, and use of immunotherapy, radioligands, and other strategies alone or in active combinations, along with guidelines for testing and treatment. In this activity, urologic oncology experts pair in-depth analysis...
2023-01-0757 minPeerView Oncology & Hematology CME/CNE/CPE Video PodcastRana R. McKay, MD, Alicia K. Morgans, MD, MPH - Alicia K. Morgans, MD, MPH - Case by Case: Maximizing Personalized Approaches to Prostate CancerGo online to PeerView.com/YGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The expanding therapeutic landscape for prostate cancer has provided new opportunities for oncology and urology professionals to improve outcomes through individualized patient care. With new and emerging strategies in both the hormone-sensitive and -resistant settings, treatment of patients with prostate cancer requires knowledge of next-generation anti-androgen agents, PARP inhibitors, and use of immunotherapy, radioligands, and other strategies alone or in active combinations, along with guidelines for testing and treatment. In this activity, urologic oncology experts pair in-depth analysis...
2023-01-0757 minPeerView Oncology & Hematology CME/CNE/CPE Audio PodcastRana R. McKay, MD, Alicia K. Morgans, MD, MPH - Alicia K. Morgans, MD, MPH - Case by Case: Maximizing Personalized Approaches to Prostate CancerGo online to PeerView.com/YGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The expanding therapeutic landscape for prostate cancer has provided new opportunities for oncology and urology professionals to improve outcomes through individualized patient care. With new and emerging strategies in both the hormone-sensitive and -resistant settings, treatment of patients with prostate cancer requires knowledge of next-generation anti-androgen agents, PARP inhibitors, and use of immunotherapy, radioligands, and other strategies alone or in active combinations, along with guidelines for testing and treatment. In this activity, urologic oncology experts pair in-depth analysis...
2023-01-0757 minPeerView Internal Medicine CME/CNE/CPE Video PodcastRana R. McKay, MD, Alicia K. Morgans, MD, MPH - Alicia K. Morgans, MD, MPH - Case by Case: Maximizing Personalized Approaches to Prostate CancerGo online to PeerView.com/YGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The expanding therapeutic landscape for prostate cancer has provided new opportunities for oncology and urology professionals to improve outcomes through individualized patient care. With new and emerging strategies in both the hormone-sensitive and -resistant settings, treatment of patients with prostate cancer requires knowledge of next-generation anti-androgen agents, PARP inhibitors, and use of immunotherapy, radioligands, and other strategies alone or in active combinations, along with guidelines for testing and treatment. In this activity, urologic oncology experts pair in-depth analysis...
2023-01-0757 minPeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastRana R. McKay, MD, Alicia K. Morgans, MD, MPH - Alicia K. Morgans, MD, MPH - Case by Case: Maximizing Personalized Approaches to Prostate CancerGo online to PeerView.com/YGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The expanding therapeutic landscape for prostate cancer has provided new opportunities for oncology and urology professionals to improve outcomes through individualized patient care. With new and emerging strategies in both the hormone-sensitive and -resistant settings, treatment of patients with prostate cancer requires knowledge of next-generation anti-androgen agents, PARP inhibitors, and use of immunotherapy, radioligands, and other strategies alone or in active combinations, along with guidelines for testing and treatment. In this activity, urologic oncology experts pair in-depth analysis...
2023-01-0757 minGU Cast | Urology PodcastThe PCF Retreat 2022 | Highlights from CarlsbadThe annual Prostate Cancer Foundation (PCF) Retreat is in its 29th year, and is the showpiece event of the PCF's incredible research program. Each year, PCF investigators from around the world gather in California to share their work and interact together. Fair to say it has developed a legendary status among the prostate cancer community across the globe. GU Cast's Dr Renu Eapen has recently received a PCF Young Investigator Award to support her PhD into immunological aspects of prostate cancer in patients receiving Lu-PSMA on the LuTectomy trial, so she was excited to travel to Carlsbad (CA...
2022-12-1250 minPeerView Internal Medicine CME/CNE/CPE Video PodcastAlicia K. Morgans, MD, MPH - Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient CareGo online to PeerView.com/XGS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Two experts highlight how a prostate cancer care team can use the latest clinical evidence, treatment guidelines, and consensus recommendations to improve outcomes for patients with prostate cancer and will give practical insights on applying next-generation anti-androgen agents, PARP inhibitors, and chemotherapy to the prostate cancer treatment landscape. By providing a “roadmap” to the multiple pathways of prostate cancer management, this program serves as a resource for professionals interested in the present and future applications of new science in p...
2022-11-181h 05PeerView Internal Medicine CME/CNE/CPE Audio PodcastAlicia K. Morgans, MD, MPH - Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient CareGo online to PeerView.com/XGS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Two experts highlight how a prostate cancer care team can use the latest clinical evidence, treatment guidelines, and consensus recommendations to improve outcomes for patients with prostate cancer and will give practical insights on applying next-generation anti-androgen agents, PARP inhibitors, and chemotherapy to the prostate cancer treatment landscape. By providing a “roadmap” to the multiple pathways of prostate cancer management, this program serves as a resource for professionals interested in the present and future applications of new science in p...
2022-11-181h 05PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastAlicia K. Morgans, MD, MPH - Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient CareGo online to PeerView.com/XGS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Two experts highlight how a prostate cancer care team can use the latest clinical evidence, treatment guidelines, and consensus recommendations to improve outcomes for patients with prostate cancer and will give practical insights on applying next-generation anti-androgen agents, PARP inhibitors, and chemotherapy to the prostate cancer treatment landscape. By providing a “roadmap” to the multiple pathways of prostate cancer management, this program serves as a resource for professionals interested in the present and future applications of new science in p...
2022-11-181h 05PeerView Oncology & Hematology CME/CNE/CPE Video PodcastAlicia K. Morgans, MD, MPH - Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient CareGo online to PeerView.com/XGS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Two experts highlight how a prostate cancer care team can use the latest clinical evidence, treatment guidelines, and consensus recommendations to improve outcomes for patients with prostate cancer and will give practical insights on applying next-generation anti-androgen agents, PARP inhibitors, and chemotherapy to the prostate cancer treatment landscape. By providing a “roadmap” to the multiple pathways of prostate cancer management, this program serves as a resource for professionals interested in the present and future applications of new science in p...
2022-11-181h 05PeerView Clinical Pharmacology CME/CNE/CPE VideoAlicia K. Morgans, MD, MPH - Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient CareGo online to PeerView.com/XGS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Two experts highlight how a prostate cancer care team can use the latest clinical evidence, treatment guidelines, and consensus recommendations to improve outcomes for patients with prostate cancer and will give practical insights on applying next-generation anti-androgen agents, PARP inhibitors, and chemotherapy to the prostate cancer treatment landscape. By providing a “roadmap” to the multiple pathways of prostate cancer management, this program serves as a resource for professionals interested in the present and future applications of new science in p...
2022-11-181h 05PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastAlicia K. Morgans, MD, MPH - Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient CareGo online to PeerView.com/XGS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Two experts highlight how a prostate cancer care team can use the latest clinical evidence, treatment guidelines, and consensus recommendations to improve outcomes for patients with prostate cancer and will give practical insights on applying next-generation anti-androgen agents, PARP inhibitors, and chemotherapy to the prostate cancer treatment landscape. By providing a “roadmap” to the multiple pathways of prostate cancer management, this program serves as a resource for professionals interested in the present and future applications of new science in p...
2022-11-181h 05
Research To Practice | Oncology VideosProstate and Bladder Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer SpecialistsProceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in prostate and bladder cancers. Featuring perspectives from Drs Alicia Morgans and Evan Yu, including the following topics: Treatment for Prostate Cancer (0:00) Caring for Patients with Bladder Cancer (36:30) CME information and select publications
2022-11-161h 02
Prostate Cancer UpdateThe Clinical Implications of Key Recent Data Sets in Prostate and Bladder Cancers — With Drs Alicia Morgans and Evan Yu (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in prostate and bladder cancers. Featuring perspectives from Drs Alicia Morgans and Evan Yu, moderated by Dr Neil Love.
2022-11-161h 02
AUAUniversitySystemic Therapies for mHSPC and Castrate Resistant Prostate CancerSystemic Therapies for Metastatic Hormone Sensitive Prostate Cancer and Castrate Resistant Prostate Cancer
Host: Jay D. Raman, MD, FACS
Co-Host: Alicia Morgans, MD, MPH and Kelly Stratton, MD
CME Available: auau.auanet.org/node/37317
At the conclusion of this activity, participants will be able to:
1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients.
2. Prioritize or stratify treatment options for metastatic prostate cancer.
3. Describe the mechanism of action and role of immune checkpoint inhibitors for advanced prostate cancer.
4. Identify management of side effects and adverse events that patients experience for systemic therapies for advanced prostate...
2022-11-0937 min
COR2ED Medical EducationShared decision-making in nmCRPCShared decision-making in nmCRPC: Treatment considerations to maintain quality of life
COR2ED Medical Education: Brenda Martone, a nurse practitioner at Northwestern Medicine in Chicago Illinois and Dr Alicia Morgans, Genitourinary Medical Oncologist at the Dana-Farber Cancer Institute in the United States discuss ‘Shared decision-making in nmCRPC: Treatment considerations to maintain quality of life’ in this GU CONNECT podcast.
In this podcast, the experts discuss how patients are more likely to be able to adhere to a treatment plan if they understand their choices and the implications of each treatment.
They discuss how nmCRP...
2022-07-1123 min
Research To Practice | Oncology VideosProstate Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual MeetingFeaturing perspectives from Drs Andrew Armstrong, Alan Bryce and Alicia Morgans, including the following topics: Introduction (0:00) Case: A man in his early 70s with DIPSS low- to intermediate-risk post-essential thrombocythemia myelofibrosis (MF) — Warren S Brenner, MD (5:29) Case: A woman in her late 60s with primary MF who experiences disease progression after 3 years of ruxolitinib — Jeanne Palmer, MD (17:19) Case: A woman in her late 60s with disease progression after multiple regimens for post-polycythemia vera MF — Neil Morganstein, MD (30:51) A woman in her late 70s with post-PV MF with a JAK2 V617F mutation and transfusion dependence — Bhavana (Tina) Bhatnagar, DO (39:3...
2022-06-221h 01AUAUniversityLive from AUA2022: Highlights in Advanced Prostate CancerCME Available: https://auau.auanet.org/node/35710
Course Director: Stephen A. Boorjian, MD
Faculty: Leonard G. Gomella, MD, FACS; David F. Jarrard, MD; Alicia K. Morgans, MD, MPH
ACKNOWLEDGMENTS:
This educational activity is supported by independent education grants from:
Astellas
AstraZeneca
Merck & Co., Inc.
Pfizer, Inc.
At the conclusion of the activity, participants will be able to:
LEARNING OBJECTIVES:
1. Describe recent developments in the medical management of advanced prostate cancer.
Identify the active agents and their mechanism of action in the management of mHSPC, nmCRPC and mCRPC.
2. Discuss clinical investigations in the treatment of advanced prostate cancer.
3. Analyze the risks...
2022-05-1659 min
Decera Clinical Education APP PodcastASCO Genitourinary Cancers Symposium, 2022: A Focus on Prostate CancerIn this podcast, Dr. Alicia Morgans discusses recent data presented at the 2022 ASCO GU Cancers Symposium, including trials evaluating the use of first-line PARP inhibitors in combination with abiraterone for mCRPC, continuation of enzalutamide after progression, and imaging modalities as predictive and prognostic biomarkers. This activity is available for CE/CME credit. Claim your credit at pce.is/ascogu.Contributors: Dr Morgans has disclosed that she has received funds for research support from Atellas, AstraZeneca, Bayer, Myovant, and Pfizer, and consulting fees from AAA, Astellas, AstraZeneca, Bayer, Blue Earth, Clovis, Dendreon, Janssen, Lantheus, Merck, Myovant, No...
2022-03-1727 min
COR2ED Medical EducationProstate Cancer Highlights from ASCO GU 2022COR2ED Medical Education: Dr Alicia Morgans, Genitourinary Medical Oncologist at the Dana-Farber Cancer Institute in the United States and Dr. Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States discuss ‘Prostate Cancer Highlights from ASCO GU 2022’ in this GU CONNECT podcast.
In this podcast, the experts review data from a number of key plenary sessions from ASCO GU 2022 and discuss potential implications for clinical practice. The ARASENS trial is covered first which looked at triplet therapy in the form of ADT plus docetaxel and darolutamide in pati...
2022-03-0838 minCOR2ED Medical EducationProstate Cancer highlights from ASCO GU 2022COR2ED Medical Education: Dr Alicia Morgans, Genitourinary Medical Oncologist at the Dana-Farber Cancer Institute in the United States and Dr. Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States discuss ‘Prostate Cancer Highlights from ASCO GU 2022’ in this GU CONNECT podcast.
In this podcast, the experts review data from a number of key plenary sessions from ASCO GU 2022 and discuss potential implications for clinical practice. The ARASENS trial is covered first which looked at triplet therapy in the form of ADT plus docetaxel and darolutamide in pati...
2022-03-0838 min
COR2ED Medical EducationPARP inhibitors in prostate cancer: Management of adverse events and the importance of communication with patientsCOR2ED Medical Education: Dr Jason Alcorn, nurse consultant for Uro-Oncology & Andrology at the Mid Yorkshire Hospitals NHS Trust, United Kingdom and Dr Alicia Morgans, Genitourinary Medical Oncologist and Medical Director of the Survivorship Program at the Dana-Farber Cancer Institute in the United States, discuss 'PARP inhibitors in prostate cancer: Management of adverse events and the importance of communication with patients’ as part of the GU NURSES CONNECT podcast series covering ‘PARP inhibitors in prostate cancer’.
In this podcast, the experts discuss adverse events associated with PARP inhibitors and the management of them, in particular thrombocytopenia, gastrointestinal effect...
2022-02-1026 min
UrologyKeeping Pace in GU Cancers: Clinical Considerations for Prostate Cancer – Global Perspectives
Host: Johann de Bono, MD, PhD
Guest: Alicia K. Morgans, MD, MPH
Prostate cancer is the second most common cancer in incidence and the fifth most frequent cause of cancer-related mortality in men worldwide. With the broader availability of PSA screenings, the incidence of disease is only rising. This lively discussion focused on prostate cancer is designed to help you keep pace in GU cancers. You will enhance your knowledge and skills related to targeted therapy in patients with metastatic castrate-resistant prostate cancer, discover relevant biomarkers in prostate cancer, follow a patient case example, and...
2021-10-2900 min
Decera Clinical Education Oncology PodcastExpert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate CancerIn this episode, Daniel W. Lin, MD; Alicia K. Morgans, MD, MPH; and David F. Penson, MD, answer audience questions from a live CCO webinar focused on current best practices and emerging strategies in androgen deprivation therapy, with questions including:How to select between GnRH agonists and antagonists for initial androgen deprivation therapy?How should androgen receptor inhibitors be incorporated into treatment paradigms for nonmetastatic castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer?How should patients with prostate cancer and bone density issues be managed?How should nonmetastatic and metastatic prostate cancer be classified in light of novel...
2021-10-0719 min
Decera Clinical Education Oncology PodcastThe Latest Advances and Guidance in Nonmetastatic Castration-Resistant Prostate CancerIn this episode, Karim Fizazi, MD, PhD, and Alicia K. Morgans, MD, MPH, discuss the clinical implications of the latest data on androgen receptor–targeting agents in the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC). Topics include:Updated safety and patient preference data from the ARAMIS and ODENZA trialsChoice of apalutamide, darolutamide, and enzalutamideCounseling patients on adverse eventsManaging patients with asymptomatic nonmetastatic CRPCPresenters:Karim Fizazi, MD, PhDFull ProfessorCancer MedicineGustave RoussyVillejuif, France Alicia K. Morgans, MD, MPHAssociate ProfessorDivision of Onc...
2021-07-3021 minGU Cast | Urology PodcastPCF Global Webinar | The VISION TrialGU Cast once again joins up with our friends at the Prostate Cancer Foundation (PCF), and the Prostate Cancer Imaging & Theranostics Centre of Excellence (ProsTIC) at Peter MacCallum Cancer Centre to bring you another Global Webinar focussing on PSMA theranostics. Today's webinar features the VISION trial, recently published in the New England Journal of Medicine, and includes the first and senior authors, Dr.s Oliver Sartor and Michael Morris. We also welcome panellists Dr Alicia Morgans, Associate Professor Sze-Ting Lee, Dr James Buteau, and our co-hosts from the PCF, Dr Howard Soule and Dr Andrew Miyahira. This w...
2021-07-221h 30
Healthcare UnfilteredEpisode 20: ASCO-GU Virtual Meeting Round-Up With Toni ChoueiriToni Choueiri (@DrChoueiri), MD, Dana-Farber Cancer Institute, joins the show to guest host a discussion with Rana McKay (@DrRanaMcKay), MD, UC San Diego, and Alicia Morgans (@CaPsurvivorship), MD, MPH, Northwestern University, on the practice-changing abstracts presented at the 2020 ASCO-GU virtual meeting. The trio weigh the importance and real-world implications of the ACIS study for mCRPC, EV-301 for advanced or metastatic urothelial carcinoma as well as CheckMate 274 for muscle-invasive disease, CLEAR for first-line treatment of advanced RCC, and so much more.
2021-03-021h 17
Money Talk with RegEpisode 6: Investing in Real EstateWhat do we need to consider to invest in the real estate scene in Australia?
We cover off property in (my home town) Gladstone, QLD and more generally, in Queensland. And are the southerners really taking over??!
I have so many questions to ask our property guru, Alicia, from Locations Estate Agent.
Listen in as we cover off on what real estate agents do, how to pick one, what does investing in property look like inside and outside your postcode and whether residential, commercial or industrial is better?!
Not to mention, what about a...
2021-02-2854 minAUAUniversityCase-Based Discussion: Early M1 CRPC Management and Advanced M1 CRPCPresented by Kelly Stratton, MD and Alicia Morgans, MD
This educational activity is supported by independent educational grants from:
AbbVie
Astellas
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck
Pfizer, Inc.
CME Available: https://auau.auanet.org/node/30123
2020-12-1834 minGU Cast | Urology PodcastUrotoday and GU Cast get togetherToday we hook up with our good friends at Urotoday.com. Dr Alicia Morgans interviews Professor Declan Murphy for the Urotoday.com website, and we are cross-posting as a GU Cast podcast, introduced by Dr Renu Eapen. Alicia interviews Declan about the COVID situation in Australia as part of the Urotoday.com global overview.
2020-05-1716 minAUAUniversityComorbidities in Advanced Prostate CancerCo-Host: Alicia K. Morgans, MD, MPH
At the conclusion of these activities, participants will be able to:
1. Recognize cardiovascular comorbidities and describe their management in the context of prostate cancer treatment.
2. Differentiate the roles of the urologist, other specialists and primary care providers in the care of patients with prostate cancer.
CME Available: https://auau.auanet.org/node/26059
This educational series is supported by independent educational grants from:
Amgen
Astellas
AstraZeneca
Bristol-Myers Squibb
Genomic Health
Merck
Pfizer, Inc.
Sanofi Genzyme
UroGen Pharma
2019-11-2728 min
The Fear The Walking Dead PodcastFear the Walking Dead S:4 | Blackjack E:13 | AfterBuzz TV AfterShowOur panel discusses the ever growing feud between Morgans group and emerging villain, The filthy woman. John and Strand are “strand”ed and need to find a way back to their people. We also talk about Luciana and her unlikely friendship with a new character.
RSS Feed: http://www.afterbuzztv.com/aftershows/fear-the-walking-dead-afterbuzz-tv-aftershow/feed/
ABOUT FEAR THE WALKING DEAD:
Fear the Walking Dead is an American television series created by Robert Kirkman and Dave Erickson. It is a spin-off and a prequel series to the horror drama television series The Walking Dead, which is based on the...
2018-09-0942 min
The Fear The Walking Dead PodcastFear the Walking Dead S:4 | The Code E:11 | AfterBuzz TV AfterShowOur Panel, Timothy Michael, Danny Royce, April Whisenhant, and Krista Flentje, is introduced to three new characters as they follow Morgans inner struggle to continue to Virginia or go back to Texas to save his new friends. We also discuss a potential new big bad that may be an issue in the future.
RSS Feed: http://www.afterbuzztv.com/aftershows/fear-the-walking-dead-afterbuzz-tv-aftershow/feed/
ABOUT FEAR THE WALKING DEAD:
Fear the Walking Dead is an American television series created by Robert Kirkman and Dave Erickson. It is a spin-off and a prequel series to the horror drama te...
2018-08-2625 min